Maintenance Therapy with Intravesical Bacillus Calmette-Guérin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer

By Muto Satoru   Nakajima Akiko   Horiuchi Akira   Inoue Masayuki   China Toshiyuki   Saito Keisuke   Isotani Shuji   Hisasue Shin-ichi   Yamaguchi Raizo   Ide Hisamitsu   Horie Shigeo  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 3, 2013-03 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1113-1116

Science Publishers

Access to resources Recommend Favorite

Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

By                  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 459-464

Spandidos Publications

Access to resources Recommend Favorite

The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 4, 2013-08 ,pp. : 278-283

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of intravesical Bacillus Calmette-Guérin therapy against tumor immune escape in an orthotopic model of bladder cancer

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 1, 2015-01 ,pp. : 162-166

Spandidos Publications

Access to resources Recommend Favorite